Related references
Note: Only part of the references are listed.Comparative Effects of Curcumin versus Nano-Curcumin on Insulin Resistance, Serum Levels of Apelin and Lipid Profile in Type 2 Diabetic Rats
Ali Shamsi-Goushki et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with nonalcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
Seyed Ali Jazayeri-Tehrani et al.
NUTRITION & METABOLISM (2019)
The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial
Mahsa Adibian et al.
PHYTOTHERAPY RESEARCH (2019)
Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial
Sara Asadi et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2019)
The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial
Homa Hodaei et al.
DIABETOLOGY & METABOLIC SYNDROME (2019)
The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease
Saeede Saadati et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)
The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Reza Tabrizi et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Curcumin Activates AMPK Pathway and Regulates Lipid Metabolism in Rats Following Prolonged Clozapine Exposure
Zhen Liu et al.
FRONTIERS IN NEUROSCIENCE (2017)
A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels
Amirhossein Sahebkar
CLINICAL NUTRITION (2014)
Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial
Yunes Panahi et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2014)
Metabolic Syndrome
Susan L. Samson et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2014)
Curcumin improves endothelial dysfunction and vascular remodeling in 2K-1C hypertensive rats by raising nitric oxide availability and reducing oxidative stress
Orachorn Boonla et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2014)
Lipid-Lowering Effects of Curcumin in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
Yi-Sun Yang et al.
PHYTOTHERAPY RESEARCH (2014)
Curcumin, a component of turmeric: From farm to pharmacy
Subash C. Gupta et al.
BIOFACTORS (2013)
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Ronald Goldenberg et al.
CANADIAN JOURNAL OF DIABETES (2013)
Curcumin as a Potent and Selective Inhibitor of 11β-Hydroxysteroid Dehydrogenase 1: Improving Lipid Profiles in High-Fat-Diet-Treated Rats
Guo-Xin Hu et al.
PLOS ONE (2013)
Curcumin Extract for Prevention of Type 2 Diabetes
Somlak Chuengsamarn et al.
DIABETES CARE (2012)
Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2
J. Wouter Jukema et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice
Kwon-Il Seo et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Use and abuse of HOMA modeling
TM Wallace et al.
DIABETES CARE (2004)
Share Paper
